Us Congress 2023-2024 Regular Session

Us Congress House Bill HB7974

Introduced
4/12/24  
Refer
4/12/24  

Caption

To amend the Federal Food, Drug, and Cosmetic Act to require labeling of food products containing insects, and for other purposes.

Impact

The introduction of HB 7974 is designed to significantly impact consumer rights and food safety regulations. The requirement for explicit labeling will likely influence the food industry by standardizing practices across companies selling insect-containing products. This change could lead to an increased awareness among consumers about what they are consuming, potentially affecting market dynamics as companies may need to adapt their packaging and marketing strategies. Furthermore, the bill may encourage food producers to consider the implications of using insects as an ingredient and how that affects consumer perception and choice.

Summary

House Bill 7974 aims to amend the Federal Food, Drug, and Cosmetic Act to require clear labeling of food products containing insects and insect-derived ingredients. This legislation seeks to enhance transparency for consumers regarding the ingredients used in their food products. By mandating that any food item containing one or more insects prominently displays this information on the front label, the bill aims to inform consumers who may have dietary preferences or restrictions concerning insect consumption. The measure is proposed to take effect 180 days after enactment, applying to food introduced into interstate commerce thereafter.

Contention

While the bill may seem straightforward in its aim to improve labeling, it could face debates surrounding its necessity and implications. Supporters of the legislation argue that consumers have the right to know what is in their food, especially as entomophagy (the consumption of insects) becomes more mainstream. However, opponents may raise concerns about the regulatory burden on food businesses, particularly smaller producers who may find compliance with such labeling requirements challenging. Additionally, there may be a broader discussion about consumer fear and misperception regarding food products containing insects, and whether such labeling may inadvertently stigmatize these items.

Companion Bills

No companion bills found.

Previously Filed As

US HB10370

To amend the Federal Food, Drug, and Cosmetic Act to establish certain labeling requirements for caffeine, and for other purposes.

US HB2111

To amend the Federal Food, Drug, and Cosmetic Act to exempt the premium cigar industry from certain regulations.

US HB8123

To amend the Federal Food, Drug, and Cosmetic Act to establish new prohibited acts relating to dietary supplements.

US HJR99

To amend the Federal Food, Drug, and Cosmetic Act to exempt the premium cigar industry from certain regulations.

US HB10406

To amend the Federal Food, Drug, and Cosmetic Act to authorize requiring the manufacturers of a covered device to disclose to a patient all patient-specific data that is recorded or transmitted by the device and accessible to the manufacturer, and for other purposes.

US HB3839

To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.

US HB1843

To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.

US HB7827

To amend the Federal Food, Drug, and Cosmetic Act to encourage the development of vaccines to prevent, treat, or mitigate opioid, cocaine, methamphetamine, or alcohol use disorder, to establish an x-prize for the development of such a vaccine, and for other purposes.

US HB1051

To amend the Federal Food, Drug, and Cosmetic Act to allow for the approval of an abbreviated new drug application submitted by a subsequent applicant in the case of a failure by a first applicant to commence commercial marketing within a certain period, and for other purposes.

US SB5103

Food and Drug Administration Foods Accountability Act

Similar Bills

No similar bills found.